ArticlePloS one2025
Association between the ratio of serum uric acid to high density lipoprotein cholesterol and depressive symptoms in middle-aged and elderly Chinese.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The uric acid-to-HDL ratio as a predictive biomarker for depression risk in adult women.Frontiers in psychiatry · 2025Article
- Admission uric acid to HDL-C ratio predicts 90-day post-stroke depression in acute ischemic stroke.Frontiers in psychiatry · 2025Article
- Uric acid and HDL-C-derived inflammatory ratios as biomarkers in schizophrenia and major depressive disorder: a retrospective study.Frontiers in psychiatry · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPrevious studies have reported that metabolic syndrome is associated with depression. In recent years, the ratio of uric acid to high-density lipoprotein cholesterol (UHR) has been considered as a new effective marker of metabolic syndrome. The purpose of this study was to investigate the association between UHR and depression in people aged 45 years and older in China using the China Health and Retirement Longitudinal Study(CHARLS) database.
methodsA total of 10,396 subjects aged 45 years and above were included in this cross-sectional study. The Center for Epidemiologic Studies Depression Scale (CESD-10) was used to facilitate rapid screening and assessment of depression. A CESD-10 score of ≥ 10 was considered the critical value of depression. UHR was calculated from the ratio of serum uric acid (mg/dL) to high-density lipoprotein cholesterol (mg/dL). Linear regression and logistic regression were used to explore the relationship between UHR and depression, respectively. In addition, subgroup analysis and interaction tests were performed.
resultsThe study found that UHR was negatively associated with depression. In the fully adjusted model, every 1-unit increase in UHR was associated with a 14% lower odds of developing depression (OR = 0.14, 95% CI: 0.05-0.37). Participants in the highest quartile of UHR were 24% less likely to develop depression compared with participants in the lowest quartile (OR = 0.76, 95% CI: 0.67-0.87). The interaction analysis indicates that this negative correlation is more pronounced in the subgroup aged 60 years and above.
conclusionUHR was significantly negatively correlated with depressive symptoms in the middle-aged and elderly Chinese population. However, further prospective studies are needed to accurately elucidate the causal relationship between increased UHR levels and the risk of depression. Therefore, larger cohort studies are needed to support these findings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.